 | • レポートコード：C9OT8836 • 出版社/出版日：Prof Research / 2019年10月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・バイオ |
| Single User | ￥444,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥562,400 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥740,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「パフォーマンス向上薬市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるパフォーマンス向上薬市場について調査・分析したレポートで、パフォーマンス向上薬の世界市場動向、市場規模、主要企業情報などが含まれています。 ・パフォーマンス向上薬産業の概要 ・パフォーマンス向上薬の製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国のパフォーマンス向上薬市場 2014年-2019年 ・世界及び中国のパフォーマンス向上薬市場現状 ・企業別分析：Taj Pharmaceuticals, Balkan Pharmaceuticals, Bayer, AstraZeneca, Novo Nordisk, BrainAlert, Douglas Laboratories, Onnit Labs, Eli Lilly And Companyなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・世界及び中国のパフォーマンス向上薬市場予測 2019年-2024年 ・パフォーマンス向上薬の産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国のパフォーマンス向上薬市場動向・課題・機会 ・新規プロジェクトへの提言・結論 |
Performance Enhancing Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Performance Enhancing Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Performance Enhancing Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Performance Enhancing Drugs market covering all important parameters.
The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Performance Enhancing Drugs industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Performance Enhancing Drugs industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Performance Enhancing Drugs Industry before evaluating its feasibility.
There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.
For competitor segment, the report includes global key players of Performance Enhancing Drugs as well as some small players. At least 9 companies are included:
* Taj Pharmaceuticals
* Balkan Pharmaceuticals
* Bayer
* AstraZeneca
* Novo Nordisk
* BrainAlert
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Performance Enhancing Drugs market in gloabal and china.
* Product Type I
* Product Type II
* Product Type III
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Athletes
* Body Builders
* Students
* Militaries
Reasons to Purchase this Report:
* Estimates 2019-2024 Performance Enhancing Drugs market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Chapter One Introduction of Performance Enhancing Drugs Industry
1.1 Brief Introduction of Performance Enhancing Drugs
1.2 Development of Performance Enhancing Drugs Industry
1.3 Status of Performance Enhancing Drugs Industry
Chapter Two Manufacturing Technology of Performance Enhancing Drugs
2.1 Development of Performance Enhancing Drugs Manufacturing Technology
2.2 Analysis of Performance Enhancing Drugs Manufacturing Technology
2.3 Trends of Performance Enhancing Drugs Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Taj Pharmaceuticals
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Balkan Pharmaceuticals
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Bayer
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 AstraZeneca
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Novo Nordisk
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 BrainAlert
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Douglas Laboratories
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……
Chapter Four 2014-2019 Global and Chinese Market of Performance Enhancing Drugs
4.1 2014-2019 Global Capacity, Production and Production Value of Performance Enhancing Drugs Industry
4.2 2014-2019 Global Cost and Profit of Performance Enhancing Drugs Industry
4.3 Market Comparison of Global and Chinese Performance Enhancing Drugs Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Performance Enhancing Drugs
4.5 2014-2019 Chinese Import and Export of Performance Enhancing Drugs
Chapter Five Market Status of Performance Enhancing Drugs Industry
5.1 Market Competition of Performance Enhancing Drugs Industry by Company
5.2 Market Competition of Performance Enhancing Drugs Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Performance Enhancing Drugs Consumption by Application/Type
Chapter Six 2019-2024 Market Forecast of Global and Chinese Performance Enhancing Drugs Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Performance Enhancing Drugs
6.2 2019-2024 Performance Enhancing Drugs Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Performance Enhancing Drugs
6.4 2019-2024 Global and Chinese Supply and Consumption of Performance Enhancing Drugs
6.5 2019-2024 Chinese Import and Export of Performance Enhancing Drugs
Chapter Seven Analysis of Performance Enhancing Drugs Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry
Chapter Eight Global and Chinese Economic Impact on Performance Enhancing Drugs Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Performance Enhancing Drugs Industry
Chapter Nine Market Dynamics of Performance Enhancing Drugs Industry
9.1 Performance Enhancing Drugs Industry News
9.2 Performance Enhancing Drugs Industry Development Challenges
9.3 Performance Enhancing Drugs Industry Development Opportunities
Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment
Chapter Eleven Research Conclusions of Global and Chinese Performance Enhancing Drugs Industry
Tables and Figures
Figure Performance Enhancing Drugs Product Picture
Table Development of Performance Enhancing Drugs Manufacturing Technology
Figure Manufacturing Process of Performance Enhancing Drugs
Table Trends of Performance Enhancing Drugs Manufacturing Technology
Figure Performance Enhancing Drugs Product and Specifications
Table 2014-2019 Performance Enhancing Drugs Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Performance Enhancing Drugs Capacity Production and Growth Rate
Figure 2014-2019 Performance Enhancing Drugs Production Global Market Share
Figure Performance Enhancing Drugs Product and Specifications
Table 2014-2019 Performance Enhancing Drugs Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Performance Enhancing Drugs Capacity Production and Growth Rate
Figure 2014-2019 Performance Enhancing Drugs Production Global Market Share
Figure Performance Enhancing Drugs Product and Specifications
Table 2014-2019 Performance Enhancing Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Performance Enhancing Drugs Capacity Production and Growth Rate
Figure 2014-2019 Performance Enhancing Drugs Production Global Market Share
Figure Performance Enhancing Drugs Product and Specifications
Table 2014-2019 Performance Enhancing Drugs Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Performance Enhancing Drugs Capacity Production and Growth Rate
Figure 2014-2019 Performance Enhancing Drugs Production Global Market Share
Figure Performance Enhancing Drugs Product and Specifications
Table 2014-2019 Performance Enhancing Drugs Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Performance Enhancing Drugs Capacity Production and Growth Rate
Figure 2014-2019 Performance Enhancing Drugs Production Global Market Share
Figure Performance Enhancing Drugs Product and Specifications
Table 2014-2019 Performance Enhancing Drugs Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Performance Enhancing Drugs Capacity Production and Growth Rate
Figure 2014-2019 Performance Enhancing Drugs Production Global Market Share
Figure Performance Enhancing Drugs Product and Specifications
Table 2014-2019 Performance Enhancing Drugs Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Performance Enhancing Drugs Capacity Production and Growth Rate
Figure 2014-2019 Performance Enhancing Drugs Production Global Market Share
Figure Performance Enhancing Drugs Product and Specifications
Table 2014-2019 Performance Enhancing Drugs Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Performance Enhancing Drugs Capacity Production and Growth Rate
Figure 2014-2019 Performance Enhancing Drugs Production Global Market Share
……
……
Table 2014-2019 Global Performance Enhancing Drugs Capacity List
Table 2014-2019 Global Performance Enhancing Drugs Key Manufacturers Capacity Share List
Figure 2014-2019 Global Performance Enhancing Drugs Manufacturers Capacity Share
Table 2014-2019 Global Performance Enhancing Drugs Key Manufacturers Production List
Table 2014-2019 Global Performance Enhancing Drugs Key Manufacturers Production Share List
Figure 2014-2019 Global Performance Enhancing Drugs Manufacturers Production Share
Figure 2014-2019 Global Performance Enhancing Drugs Capacity Production and Growth Rate
Table 2014-2019 Global Performance Enhancing Drugs Key Manufacturers Production Value List
Figure 2014-2019 Global Performance Enhancing Drugs Production Value and Growth Rate
Table 2014-2019 Global Performance Enhancing Drugs Key Manufacturers Production Value Share List
Figure 2014-2019 Global Performance Enhancing Drugs Manufacturers Production Value Share
Table 2014-2019 Global Performance Enhancing Drugs Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Performance Enhancing Drugs Production
Table 2014-2019 Global Supply and Consumption of Performance Enhancing Drugs
Table 2014-2019 Import and Export of Performance Enhancing Drugs
Figure 2018 Global Performance Enhancing Drugs Key Manufacturers Capacity Market Share
Figure 2018 Global Performance Enhancing Drugs Key Manufacturers Production Market Share
Figure 2018 Global Performance Enhancing Drugs Key Manufacturers Production Value Market Share
Table 2014-2019 Global Performance Enhancing Drugs Key Countries Capacity List
Figure 2014-2019 Global Performance Enhancing Drugs Key Countries Capacity
Table 2014-2019 Global Performance Enhancing Drugs Key Countries Capacity Share List
Figure 2014-2019 Global Performance Enhancing Drugs Key Countries Capacity Share
Table 2014-2019 Global Performance Enhancing Drugs Key Countries Production List
Figure 2014-2019 Global Performance Enhancing Drugs Key Countries Production
Table 2014-2019 Global Performance Enhancing Drugs Key Countries Production Share List
Figure 2014-2019 Global Performance Enhancing Drugs Key Countries Production Share
Table 2014-2019 Global Performance Enhancing Drugs Key Countries Consumption Volume List
Figure 2014-2019 Global Performance Enhancing Drugs Key Countries Consumption Volume
Table 2014-2019 Global Performance Enhancing Drugs Key Countries Consumption Volume Share List
Figure 2014-2019 Global Performance Enhancing Drugs Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Performance Enhancing Drugs Consumption Volume Market by Application
Table 89 2014-2019 Global Performance Enhancing Drugs Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Performance Enhancing Drugs Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Performance Enhancing Drugs Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Performance Enhancing Drugs Consumption Volume Market by Application
Figure 2019-2024 Global Performance Enhancing Drugs Capacity Production and Growth Rate
Figure 2019-2024 Global Performance Enhancing Drugs Production Value and Growth Rate
Table 2019-2024 Global Performance Enhancing Drugs Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Performance Enhancing Drugs Production
Table 2019-2024 Global Supply and Consumption of Performance Enhancing Drugs
Table 2019-2024 Import and Export of Performance Enhancing Drugs
Figure Industry Chain Structure of Performance Enhancing Drugs Industry
Figure Production Cost Analysis of Performance Enhancing Drugs
Figure Downstream Analysis of Performance Enhancing Drugs
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Performance Enhancing Drugs Industry
Table Performance Enhancing Drugs Industry Development Challenges
Table Performance Enhancing Drugs Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Performance Enhancing Drugss Project Feasibility Study
ウェブパフォーマンス市場：世界及び中国市場分析・予測（～2024年） Web Performance Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Web Performance industry with a focus on the Chinese market. The report provides key statistics on the market status of the Web Performance manufacturers and is a…- 世界のボツリヌス中毒症薬市場予測（～2024年） Botulism is a rare and potentially fatal illness caused by a toxin produced by the bacterium Clostridium botulinum. The disease begins with weakness, blurred vision, feeling tired, and trouble speaking. This may then be followed by weakness of the arms, chest muscles, and legs. Vomiting, swelling of…
- パフォーマンスケミカルズ市場：世界及び中国市場分析・予測（～2024年） Performance Chemicals Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Performance Chemicals industry with a focus on the Chinese market. The report provides key statistics on the market status of the Performance Chemicals manu…
- ベーシック・パフォーマンス・コンバーター市場：世界及び中国市場分析・予測（～2024年） Basic Performance Converters Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Basic Performance Converters industry with a focus on the Chinese market. The report provides key statistics on the market status of the Basic Perfor…
- セールスパフォーマンス管理市場：世界及び中国市場分析・予測（～2024年） Sales Performance Management Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Sales Performance Management industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sales Perfor…